Maykl C. Snabes, MD, PhD, vice president of the clinical disclosure of the Pharmaceuticalses BioSante, will present the review of the key analysis in LibiGel progression in a continuously ascending gradation (the gel testosterone) program in Endocrine Society 90-e Annual Meeting in San Francisco in the Centre Moscone in Sunday, 15 June, 2008. The Announcement named ” Cardiovascular And Breast Safe Study Libigel In Woman with Sexual pharmacy pill Disorder of the Desire Hypoactive (HSDD): Project of the Analysis And Descriptions of the Endpoints,” - co-authored investigator and consultant in University America School Medicine, Consultants of the Berry, and M.D. The Cancerous Centre Anderson.

The Conference of the news will is organized in Sunday, 15 June, 2008, during which reporters invited to consider the announcement and discuss LibiGel and described analysis with Dr. Snabes.

BioSante CONDUCTS the safe analysis, in post-woman menopausal with hypoactive sexual health disorder of the desire (HSDD), on request USA. Food and Administration Medicine. The Request - in accordance with buzz to more safe given from Endocrine Society, of the healing art fraternity two professions, which be focused in endocrine and metabolic disease.

Dr. Snabes noted importance this preceding installing the analysis. “This clinical assess to study the long-term movables testosterone in post-woman menopausal, can subsist one of first big, cardiovascular operated events, studies pre- approvals were undertaken in the absence of lucid safe signal.”

BioSante EXPECTS that enrolled and is tested aproximately three thousandth posts-womans menopausal between time of life fifty and eighty and, What one has at least once one cardiovascular factor of the hazard. The pharmacy online Primary safe result for this test - Each effect of the processing inn incidence heartily event, including cardiovascular bound death, heart attack, and blow. Incidence invasive withstand cancer is a primary safe endpoint co-, and investigators will besides countenance the convenient breast breast cancer of the masses and non-invasives. The Patients will are evaluated for hirsutism, acne, and speech or reactions of the skin, as well as blood testosterone is justified for the time of each visit of the analysis.

HSDD is CHARACTERIZED low libido and the general defect of the interest in sex. If unhurt endpoints counter and approves the medicine, LibiGel will become first authorized processing specified for HSDD in menopausal woman. BioSante EXPECTS the approval certain time during 2010 or 2011.

The Feminine sexual dysfunction Be possible to arise out of various reasons, including problems relations, use the pharmaceuticalses of the prescription, disease, or chemical imbalances. HSDD ADDRESSES successfully and successfully with testosterone for many years though and to date not approved for this use. In terminated analysis Phase II LibiGel be noticeable excellent safety and efficiency. However, not long ago became interested cardiovascular and cancerous risk bound broad class medicine, amongst hymn potential therapy for FSD. The Safe analysis of the Phase III is intended to confirm long-term safety LibiGel’s.

The Operated analysis studies the effect LibiGel inn post-woman drugstore online menopausal in dose 300 micrograms per diem over twelve months. BioSante is SPECIFICALLY focused in heartily event and incidence breast cancer. After twelve plans of the months BioSante too apply for approval from one end to the other New Application Medicine (NDA). requires BioSante two follow the group of the analysis during additional fourty-eight months, after inferiority NDA and the right stuff approval to compare mate the warmhearted outcome and breast cancer between group of the processing and corresponding too group of the womans, who get the gel

LibiGel - a neaten 1% testosterone that woman enclose as soon during the time that day, in they’re upper lever. Measured pea mass helium carries through skin quickly, from where he delivers the firm dose testosterone on blood.

granting testosterone thought-out Viewed like male hormone, he be too discovered in woman on level approaching with their age. The Researchers believe that testosterone will justify, what fall with increasing of the years, can control the feminine sexual want. For instance, woman in her has about blood testosterone as woman in hits twenty.

Incidence HSDD also increases since life-span and after determined surgical procedures. Aproximately 14% premenopausal womans between age twenty and fourty-nine registered HSDD, in contrast with 26% womans, online pharmacy tablet who surgical have deleted their ovaries. Similarly, incidence HSDD grows before 9% for “naturally” menopausal womans. LibiGel is INTENDED to restore the level testosterone in post-womans menopausal on level, that are considered normal two fortify sound libido.

The Results of the scrutiny, which gain the preceding safe notice finally must lie to put the safe enxiety for processing testosterone in woman and lead to approval of the first secure place, efficient processing was specifically indicated During HSDD in menopausal woman.